POG Talks provide a platform for POG members to educate and disseminate research and knowledge to the members of POG, POG's affiliates, and the research community as a whole.

2019

2019

2019

Bozoky, Z.

ACCELERATE DECISION MAKING WITH THE SUPPORT OF GENOMIC AND HEALTH DATA SHARING

2019

Dixon, K.

MOLECULAR MECHANISMS OF CANCER SUSCEPTIBILITY AND IMPLICATIONS FOR GENETIC DIAGNOSIS.

2019

Eirew, P.

PROFILING SPECIFIC SENSITIVITIES OF PATIENT TUMOURS BY IN VIVO XENOGRAFT CRISPR SCREENING.

2019

Lee, M.

TREATMENT PARADIGM SHIFT IN PANCREATIC ADENOCARCINOMA WITH INCREASED GENOMIC PROFILING.

2019

Pleasance, P.

PAN-CANCER ANALYSIS OF POG TUMOUR LANDSCAPES REVEALS IMPACT OF PRIOR THERAPY.

2018

2018

Grewal, J.

POG TALKS

Automated cancer diagnosis: using machine learning to identify the site of origin of metastatic cancers.

2018

Karasinska, J.

CLINICAL RELEVANCE OF METABOLIC PLASTICITY IN PANCREATIC CANCER POG TALKS.

2018

LeVasseur, N.

WHOLE GENOME SEQUENCING IN METASTATIC BREAST CANCER — LESSONS LEARNED FROM THE BC CANCER PERSONALIZED ONCOGENOMICS (POG) PROGRAM.

2018

Liu, L.

OUTCOMES OF WHOLE GENOME AND TRANSCRIPTOME SEQUENCING (WGTS) IN METASTATIC COLORECTAL CANCER (MCRC) AND ADVANCED GYNECOLOGIC MALIGNANCIES (AGM): RESULTS FROM THE PERSONALIZED ONCOGENOMICS (POG) PROGRAM.

2018

Pearson, H.

GENOMIC BIOMARKERS OF RESPONSE TO CHECKPOINT INHIBITOR IMMUNOTHERAPY IN THE PERSONALIZED ONCOGENOMICS COHORT.

2018

Schlosser, C.

ENDOGENOUS RETROELEMENT-CONTAINING TRANSCRIPTS ARE ASSOCIATED WITH SIGNATURES OF IMMUNOGENICITY IN METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA.

2018

Thibodeau, M.L.

APOBEC3A/B GERMLINE DELETION AND SOMATIC MUTATIONAL SIGNATURES IN DIVERSE CANCERS.

2018

Topham, J.

ENRICHING TUMOUR CONTENT FOR BETTER GENOMICS.

2018

Weymann, D.

THE ECONOMICS OF APPLYING WHOLE-GENOME AND TRANSCRIPTOME ANALYSIS TO GUIDE TREATMENT FOR INCURABLE CANCERS.

2018

Williamson, L.

PANCREATIC DUCTAL ADENOCARCINOMA IN THE PERSONALIZED ONCOGENOMICS COHORT.

2017

2017

Alcaide, M.

ULTRASENSITIVE DETECTION AND MONITORING OF CIRCULATING TUMOUR DNA IN POG PATIENTS.

2017

Tessier-Cloutier, B.

GENOMIC INTEGRATIVE PATHOLOGY.

2017

Thibault, P.

PROFILING THE MHC CLASS I IMMUNOPEPTIDOME LANDSCAPE FOR CANCER IMMUNOTHERAPY.

2017

Titmuss, E.

ANGIOTENSIN RECEPTOR BLOCKER AS A POTENTIAL IMMUNOTHERAPY IN COLORECTAL CANCER; POG130 CASE STUDY.

2017

Zhao, E.

HOW POG ADVANCES GENOMIC INSTABILITY RESEARCH.

Back to top